Cosmos Health Inc. (NASDAQ:COSM) shares are trading slightly lower on Friday. The company revealed that its wholly owned ...

Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 ...

Indian pharma strengthens deploying compressed air dryers in sync with revised Schedule M norms: Nandita Vijayasimha, Bengaluru Tuesday, February 4, 2025, 08:00 Hrs [IST] Indian p ...

Cosmos Health (COSM) announced that its wholly owned subsidiary, Cana Laboratories, has entered into a new long-term ten-year contract ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Nepal Ausadhi Limited has been awarded with the Good Manufacturing Practice (GMP) certificate, meeting the World Health ...

The firm - which specialises in iron deficiency tablet Accrufer - has announced a “significant step-up in revenue” during 2024 ...

Suspending and recalling substandard drugs is a routine part of the department’s risk reduction measures. Officials said ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

SaSPinjara Life Sciences sees Indian pharma boosting capability in high-demand therapeutics: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] SaSPinjara ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

The LXM.5 pilot study reveals an 80% bioavailability increase compared to competing products combining levodopa and carbidopa. The study additionally shows sustained and smooth levodopa levels in the ...